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Abstract 
The use of on-chip multimodal sensing approaches is very promising towards integrated 
biosensing systems, which measure different parameters involved in biomolecular 
interactions and provide automated validation of true positives. In this report we investigate a 
proof of concept that enables multiple detection technologies for screening inhibitors of 
kinase activity, which is a crucial process in drug discovery applications. We demonstrate the 
integration of electrochemical techniques on the same chip, namely differential pulse 
voltammetry, impedance spectroscopy and direct open circuit potential measurements. Gold 
nanoparticles that attach to the thio-phosphorylated proteins facilitate localized surface 
plasmon resonance detection. The addition of thiolated ferrocene, which attaches to the 
nanoparticles like a crown, enables sensitive electrochemical amperometric detection of 
kinase activity. This novel multimodal biosensor provides a more rigorous measurement of 
biomolecules, with wide significance in biomedical, environmental and pharmaceutical 
applications. 
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1. Introduction 
Complementary characterisation techniques are often required in the study of biomolecular 
interactions and on the validation of biomolecular detection. Different electrochemical 
techniques can be used for fast, miniaturised biosensing systems, with each technique 
providing different information, which can then be correlated to a certain concentration of 
analyte. Often more than one technique is used to validate the biosensor or provide 
complementary information on the biological recognition system (e.g. kinetics and 
concentration). A few reports have integrated different techniques on the same measurement 
system in order to look at different properties of an interaction or validate the detection of an 
analyte [1,2]. Such integrated systems open the doors towards generic biosensors that can be 
used for a range of applications, where the user selects which techniques to use according to 
the properties of the biomolecule to be measured or the information required. 
We here describe the combination of several electrochemical (open circuit potential, 
electrochemical impedance spectroscopy, differential pulse voltammetry) and nanoplasmonic 
(localized surface plasmon resonance) techniques on a linear array of electrodes in a flow 
cell. These have been applied for the detection of protein phosphorylation driven by kinases. 
Abnormal phosphorylation of proteins, interceded by kinases, is an important cellular 
regulation in several aspects of neoplasia [3]. Furthermore, there are over 400 diseases now 
linked either directly or indirectly to the activity of protein kinases [4-7]. This makes protein 
kinases an abundant source of potential drug targets to intervene in several diseases. 
However, the current kinase inhibitor drug market is very premature with less than 30 protein 
kinase inhibitors approved by the United States Food and Drug Administration until 2014 [8]. 
This is primarily due to the time consuming, cost inefficient and laborious detection 
techniques, like mass spectroscopy and western blot, used in pharmaceutics to understand the 
kinase activity. In addition, some of these assays require the usage of toxic chemical reagents, 
such as radioactive tags/label, and are unsuitable for high-throughput applications [9]. The 
need to develop high-throughput biosensors that are capable of screening large libraries of 
kinase inhibitors is therefore very high. In this work, we present a novel 3-step assay that 
enables parallel detection of protein phosphorylation by multiple electrochemical and 
nanoplasmonic techniques. In the first step, phosphorylation of myelin basic protein by PKC-
α kinase is achieved by using 5'-[γ-thio] triphosphate (ATP-S) as a source of phosphate in the 
presence and absence of known inhibitor PKC-α, GF 109203X. The phosphorylation process 
is monitored in real time using an in-house built open circuit potential (OCP) measurement 
system. In the second step, gold nanoparticles are added to the reaction, which attach 
spontaneously to the thio-phosphoryl groups. This facilitates detection of phosphorylated 
proteins using a localized surface plasmon resonance technique as reported in our previous 
work [2,10]. Finally, in the last step thiolated ferrocene (Fc) is added to the system, which is 
grafted onto the gold nanoparticles allowing detection of phosphorylation using differential 
pulse voltammetry (DPV) and electrochemical impedance spectroscopy (EIS).  
These techniques act as complementary biosensors to each other, providing on-chip self-
validation of the results for effective and reliable measurements. The application of this 
multimodal approach towards the detection of protein phosphorylation, serves as an example 
on how the engineering of the biorecognition interaction enables the use of signal probes, 
such as nanoparticles and redox molecules, that are only bound to the surface in the case of a 
true positive signal.  
 
2. Experimental 
2.1 Reagents 
All chemicals were of analytical grade and were used as received, unless otherwise specified. 
Aqueous solutions were made with double de-ionised water, 18.2 MΩ cm, with a Pyrogard 
filter (Millipore, USA). Tris base, magnesium chloride (MgCl2), sodium chloride (NaCl), 
acetone, mercaptoundecanoic acid (MUA), 6-mercapto-1-hexanol (MCH), 6-
(ferrocenyl)hexanethiol, ethanolamine, ethanol, N-hydroxysuccinimide (NHS), ethyl-
dimethylaminopropyl carbodiimide (EDC), 3-(N-morpholino)propanesulfonic buffer 
(MOPS), PKC-α kinase inhibitor GF 109203X, 5'-[γ-thio] triphosphate (ATP-S) and gold 
nanoparticles (20 nm average spherical diameter, in 0.1 mM PBS) were purchased from 
Sigma-Aldrich (UK). Dephosphorylated myelin basic protein (MBP) and PKC lipid activator 
were purchased from Millipore. PKC-α human recombinant kinase produced in Sf9, was 
procured from ProSpec-Tany TechnoGene Ltd (Israel). 
2.2 Protein phosphorylation assay 
The biosensor principle is described in Figure 1. A mixed self-assembled monolayer (SAM) 
made of 1 mM MUA and MCH in a ratio of 1:9 MUA:MCH was immobilized overnight onto 
gold electrodes. In order to cover possible pinholes on the gold surface and to reduce non-
specific binding, a 1 h backfilling step was performed with 1 mM MCH. All further 
modification steps were carried out under a flow rate of 100 µl/min using a peristaltic pump 
(Watson Marlow 323-Du) and an in-house built polytetrafluoroethylene (PTFE) flow cell 
with an inner chamber of approximate dimensions 25×8×5 mm3 (length × width × height) 
and an internal volume of 1 ml accommodating the array of electrodes. The SAM was 
activated by injecting 1 ml of an aqueous mixture of 40 mg/ml EDC and 10 mg/ml NHS. For 
protein attachment, 200 µl of 156 µM MBP protein (in 10 mM MOPS pH 7.0 containing 
128 mM MgCl2, 641 mM EDTA, 1.134 µg inactive lambda phosphatase and 0.05% sodium 
azide) were flown into the cell; unreacted carboxyl groups were blocked using 500 µl of 
10 mM ethanolamine, pH 8.5, in aqueous solution. Phosphorylation of MBP was carried out 
in 10 mM Tris base, pH 7.4 containing 6 mM NaCl and 0.4 mM MgCl2. (hereafter referred to 
as reaction buffer). The whole reaction volume was fixed to 100 µl for all replicates and their 
controls. 1 µM ATP-S and 4 units of PKC-α (1 unit per 25 µl) were subsequently added. To 
initiate the phosphorylation reaction, 5 µl of PKC lipid activator (1:20 of reaction volume) 
containing 0.5 mg/ml phosphatidylserine and 0.05 mg/ml diacyglycerol in 20 mM MOPS (pH 
7.2), 25 mM β-glycerol phosphate, 1 mM sodium orthovanadate, 1 mM dithiothretiol and 
1 mM CaCl2, was added. Control reactions were performed by adding 0.1 µM PKC kinase 
inhibitor (GF 109203X) to the phosphorylation reaction.  
 
2.3 Electrochemical measurements  
A CompactStat potentiostat (Ivium Technologies, The Netherlands) was used to perform 
impedance measurements and DPV in a three-electrode cell with an Ag/AgCl reference 
electrode (BASi, USA) and a platinum wire counter electrode (ALS, Japan). A linear array of 
4 gold electrodes with 2 mm diameter was prepared in-house by thermal evaporation (BOC 
Edwards, USA) of 20 nm Cr and 100 nm Au on glass slides. The electrode array was 
sonicated for 3 min in acetone followed by rinsing with ethanol and then ultrapure water. 
Impedance measurements were recorded in the above mentioned reaction buffer, scanning 
the frequency between 100 KHz and 0.1 Hz applying a 10 mV a.c. voltage superimposed to 
the OCP. Since an ideal impedimetric sensor will measure the response at a single frequency 
rather than for a wide spectrum, localized values of resistance (Rl) and capacitance (Cl) were 
used for comparing the EIS signals. Rl and Cl were measured at the frequency that minimizes 
the imaginary response of the complex capacitance (defined as 1/jωZ) – in our system this 
was observed to be at 1 Hz throughout the different steps. Moreover, recording an EIS signal 
for a single frequency allowed to shorten the time of the measurement from ~3.5 min 
(sweeping the whole frequency range) to ~20 s. DPV was performed to monitor the Fc peak 
scanning the potentials vs Ag/AgCl and each measurement could be performed in ~10 s. All 
the measurements were carried out at least in triplicates. 
2.4 Open Circuit Potential 
The open circuit potential was measured in real time using a complete monolithic FET-input 
ultra low input bias current instrumentation amplifier INA116 (Texas Instruments, USA) 
[11]. Difet® inputs, a very low input bias current of 3 fA at 25°C, with special guarding 
techniques were used to achieve the very low input bias current performance and provide an 
accurate differential measurement. The circuit was designed in house with 4 amplifiers 
operated at ±15 V on a single PCB circuit board. A power supply circuit was made to provide 
±15 V to minimise the mismatch of the power rails. The outputs of the amplifiers are 
connected to a 4 channel-input analog-to-digital converter with input resolution of 24bits 
measuring a range of ±1 V (NI 9219 DAQ, National Instruments, UK). The array of 4 
functionalized gold electrodes and the Ag/AgCl reference electrode were connected directly 
to the differential inputs of the amplifiers, with a platinum wire immersed in the cell 
connecting the electrolyte to ground to prevent common-mode rejection. LabVIEW (National 
Instruments, UK) was used to monitor and capture the open circuit potential measurement in 
real time simultaneously from the 4 digital outputs of the DAQ from the amplifiers array. 
2.5 Localized surface plasmon resonance measurements 
Once the electrochemical recordings were terminated, LSPR was measured using an in-house 
built system with discrete components, all bought from Ocean Optics (USA). The system had 
3 parts: reflection probe (R400-7-UV-VIS) with both detector and light source, connected to 
a Tungsten Halogen source (LS-1-LL) and a spectroscope (USB4000-UV-VIS-ES). The data 
was obtained through absorption mode on a cross platform spectroscopy operation software 
(SPECTRASUITE) provided by Ocean Optics; each measurement lasted only a few seconds. 
 
3. Results and Discussion 
Prior to monitor thio-phosphorylation, the coverage of pinholes on the electrode surface by 
MCH backfilling was confirmed by means of EIS measurements: a decrease in capacitance 
signal of 11.3 ± 0.6% was observed, indicating the effectiveness of the backfilling process. 
OCP was monitored in real time upon thio-phosphorylation of MBP immobilised onto the 
gold electrodes in a flow cell (Fig. 2A). OCP showed a change of -30 mV upon protein thio-
phosphorylation in comparison to -1.7 mV in the presence of PKC-α kinase inhibitor. The 
negative shift indicates the addition of the negatively charged phosphate groups to MBP.  
Thio-phosphorylation events enabled an easy and rapid attachment of gold nanoparticles by 
means of sulphur bonds. The modification with gold nanoparticles and following washing 
step required only 10 min in flow conditions. Upon AuNP addition, a voltage shift between 
5.4-6.8 mV is observed in the thio-phosphorylation and inhibition reactions. This shift is 
mostly attributed to the changes in buffer conditions upon introducing gold nanoparticles (in 
0.1 mM PBS) in the flow cell. Upon addition of thiolated Fc to the system, a further OCP 
shift of 5.3 mV was recorded in the case of the thio-phosphorylated samples. However, for 
the control samples and those with inhibitors the shift was lower than 1.5 mV, which 
confirms that only a minimum amount of AuNPs is present for those samples. A further 
confirmation that the OCP signals (upon gold nanoparticles attachment) were due to the 
buffer effect was supported by the LSPR detection of nanoparticles in reflection [10]. The 
presence of gold nanoparticles was observed only for thio-phosphorylated samples (Fig. 2D): 
a consistent red shift of 5.8 ± 0.4 nm for samples where thio-phosporylation took place was 
recorded, compared to 0.9 ± 0.2 nm shift for reactions in presence of phosphorylation 
inhibitor. The gold nanoparticles attachment provided a wide surface accessible for thiolated 
ferrocene grafting. This allowed both amperometric and impedimetric detection of 
phosphorylation of the proteins. A 10 min step was required for thio-ferrocene modification 
by adding 500 µl of 1 mM 6-(Ferrocenyl)hexanethiol dissolved in ethanol and finally diluted 
1:100 in the reaction buffer. Prominent signal changes due to the electrochemical double 
layer modification were induced in electrodes where thio-phosporylation occurred by means 
of the Fc-crown-like-structure. Not only real time OCP measurements but also successive 
impedimetric and voltammetric recordings could be performed in the same cell without the 
need of changing measurement solution, simply by flowing suitable reagents to the array.  
For phosphorylation detection, impedimetric data obtained before phosphorylation were 
compared with the signal acquired upon the Fc-crowned gold nanoparticle attachment. Both 
Rl (Z’ at 1 Hz) and Cl (-1/2πf Z” at 1 Hz) changes were correlated to the presence and absence 
of kinase inhibitor as well as where thio-phosphorylation compounds (i.e. kinase, ATP-S and 
kinase activator) were not used (Fig. 2B). Percentage shifts of 32 ± 10% and -16 ± 4.8% were 
recorded for Rl and Cl, respectively, in the case of thio-phosphorylation. Negligible signal 
changes were observed for both control reactions where thio-phosphorylation compounds 
were not used (ΔRl = -1.4 ± 2.9% and ΔCl = 0.6 ± 1.9%) and where the experiment was 
carried out in presence of thio-phosphorylation compounds with addition of PKC kinase 
inhibitor (ΔRl = -0.9 ± 3.6% and ΔCl = 0.4 ± 3.1%). The former can give an indication of the 
non-specific interactions between Fc and protein. The latter is noticeably the most essential 
control for drug discovery application as it allows proving the efficacy of new possible drugs 
in terms of preventing protein phosphorylation.  
The final and perhaps most powerful tool to crosscheck the thio-phosphorylation event was 
achieved by performing DPV measurements on the same platform (Fig. 2C), which clearly 
showed the Fc peaks. An Fc peak of 1.31 ± 0.26 µA height (using baseline subtraction) was 
detected at 0.59 V, while no peak was observed for the controls. 
 
4. Conclusions 
This study describes a new multimodal biosensor approach, demonstrating the potential in 
combining multiple sensing techniques on a single platform to achieve high levels of 
accuracy and reliability in the measurements. 
This multimodal biosensor was successfully applied using a small array of electrodes in a 
flow cell for detecting phosphorylation of proteins. We tested phosphorylation of MBP by 
PKC-alpha in the presence of a known inhibitor, however this approach can be used to assay 
activity of any kinase-protein pair in the presence of known/unknown inhibitors. This opens 
opportunities to develop an integrated device with multiple sensing technologies, as 
demonstrated, for pharmaceutical industries and academia to discover drugs. Moreover, it 
also exploits simple and cost-effective consumables to build a biosensor system for screening 
inhibitors of kinase. 
Our multimodal approach can easily be translated to a range of other biosensing applications, 
such as biomedical and environmental, where different electrochemical techniques can be 
used to perform on-chip validation of true positives. The engineering of the biorecognition 
elements/reagents can allow the use of nanoparticles, redox molecules or other types of signal 
probes for signal validation and amplification.  
 
References 
[1] Z. She, K. Topping, M.H. Shamsi, N. Wang, N.W.C. Chan, H.B. Kraatz, Investigation of 
the utility of complementary electrochemical detection techniques to examine the in vitro 
affinity of bacterial flagellins for a toll-like receptor 5 biosensor. Anal. Chem. 87 (2015) 
4218-4224. DOI: 10.1021/ac5042439 
[2] N. Bhalla, M. Di Lorenzo, G. Pula, P. Estrela, Protein phosphorylation detection using 
dual-mode field-effect devices and nanoplasmonic sensors. Sci. Rep. 5 (2015) 8687. DOI: 
10.1038/srep08687 
[3] K. Parang, G. Sun, Protein kinase inhibitors in drug discovery. Pharm Sci. Enc. 27 
(2010) 1-67. DOI: 10.1002/9780470571224.pse027 
[4] P. Cohen, D.R. Alessi, Kinase drug discovery – what's next in the field? ACS Chem. 
Biol. 8 (2013) 96-104. DOI: 10.1021/cb300610s 
[5] P. Cohen, Protein kinases – the major drug targets of the twenty-first century? Nat. Rev. 
Drug Discov. 1 (2002) 309-315. DOI: 10.1038/nrd773 
[6] H. Weinmann, R. Metternich, Drug discovery process for kinase inhibitors. 
ChemBioChem 6 (2005) 455-459. DOI: 10.1002/cbic.200500034 
[7] E. ter Haar, W.P. Walters, S. Pazhanisamy, P. Taslimi, A.C. Pierce, G.W. Bemis, F.G. 
Salituro, S.L. Harbeson, Kinase chemogenomics: targeting the human kinome for target 
validation and drug discovery. Mini Rev. Med. Chem. 4 (2004) 235-253. DOI: 
10.2174/1389557043487367 
[8] R. Roskoski Jr., USFDA approved protein kinase inhibitors. 
http://www.brimr.org/PKI/PKIs.htm. Last accessed 1 May 2015 
[9] S. Laufer, S. Thuma, C. Peifer, C. Greim, Y. Herweh, A. Albrecht, F. Dehner, An 
immunosorbent, nonradioactive p38 MAP kinase assay comparable to standard radioactive 
liquid-phase assays. Anal. Biochem. 344 (2005) 135-137. DOI: 10.1016/j.ab.2005.06.015 
[10] N. Bhalla, N. Formisano, A. Miodek, A. Jain, M. Di Lorenzo, G. Pula, P. Estrela, 
Plasmonic ruler on field-effect devices for kinase drug discovery applications. Biosens. 
Bioelectron. 71 (2015) 121-128. DOI: 10.1016/j.bios.2015.04.020 
[11] P. Estrela, D. Paul, P. Li, S.D. Keighley, P. Migliorato, S. Laurenson, P Ko Ferrigno, 
Label-free detection of protein interactions with peptide aptamers by open circuit potential 
measurement. Electrochim. Acta 53 (2008) 6489-6496. DOI: 10.1016/j.electacta.2008.04.036 
  
 Figure 1. Scheme for analysis of protein phosphorylation: A) Kinase assay showing (i) bare 
gold electrode, (ii) surface functionalization using MUA/MCH, (iii) protein immobilization, 
(iv) thio-phosphorylation, (v) attachment of gold nanoparticles, (vi) nanoparticles with 
attached ferrocene. B) Dummy schematic representation of the in-house built flow cell and 
measurement system for the electrochemical detection. 
 Figure 2. Representative multimodal detection of protein phosphorylation for a sample 
without inhibitor (black lines) and a sample in the presence of inhibitor (red lines): A) Real 
time OCP measurements upon injection into the flow cell of (i) ATP-S, PKC-α and PKC lipid 
activator as well as PKC-α kinase inhibitor in one sample, (ii) gold nanoparticles, (iii) Fc. 
B) Cole-Cole plot (imaginary vs. real part of the complex capacitance) for thio-
phosphorylated samples before (black line) and after Fc injection (green line); the relative 
minimum for the imaginary part of the capacitance is obtained at the frequency of 1 Hz. 
C) DPV measurements recorded after Fc injection. D) Raw LSPR spectra in the window of 
300-700 nm obtained at the end of the electrochemical experiments; the spectra for a bare 
gold sample is shown for comparison. 
 
